Pathway Genomics has added Illumina NextSeq 500 systems to its force of NGS sequencers, enhancing the company’s established and highly efficient laboratory processes.

 

The NextSeq 500’s push-button operation provides a one-day turnaround time for an array of popular sequencing applications such as a single human genome, and up to 16 exomes, 20 transcriptomes, 48 gene expression samples, 20 non-invasive prenatal samples, and 96 targeted panels. Additionally, with the sequencer’s streamlined informatics, sequencing data can be run through a range of commercial pipelines.

The NextSeq 500 provides a one-day turnaround time for an array of popular sequencing applications.

“The addition of this advanced next-generation sequencing system provides our clinical laboratory with another powerful tool in the NGS space, adding to our current capabilities,” said David Becker, Ph.D., Pathway Genomics’ chief scientific officer. “Our primary objective is to provide physicians and their patients with accurate laboratory results in a timely manner, and the NextSeq 500 is a key factor in taking us to a new level in meeting that goal.”

“The addition of this advanced next-generation sequencing system provides our clinical laboratory with another powerful tool in the NGS space, adding to our current capabilities.”

David Becker, Ph.D.
Chief Scientific Officer
Pathway Genomics

Delivering the power of high-throughput sequencing with the load-and-go simplicity of a desktop sequencer, the NextSeq 500 is the only NGS system capable of sequencing a whole human genome at high coverage in one run.

“Speed, efficiency and accuracy are key for us, and the NextSeq 500 is currently the fastest sequencer to produce results for genomes, exomes and targeted resequencing right off the bench.”

Ardy Arianpour
Chief Strategy Officer
Pathway Genomics

“Acquiring the first Illumina NextSeq 500 sequencers sets our company apart from other competitors in the clinical diagnostic space,” said Ardy Arianpour, Pathway Genomics’ chief strategy officer. “Speed, efficiency and accuracy are key for us, and the NextSeq 500 is currently the fastest sequencer to produce results for genomes, exomes and targeted resequencing right off the bench.”

Comments are closed.